.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical evidence suggests that sNfL and atrial fibrillation outcomes are inextricably linked. While serum neurofilament light chain (sNfL) is primarily known as a marker for neuronal injury, its role in predicting cardiovascular risk is becoming clearer. The Swiss Atrial Fibrillation Cohort (SWISS-AF) study recently provided definitive data on this association in a large patient population.
Researchers analyzed 2,311 patients with atrial fibrillation (AF) over a median of eight years. They found that sNfL levels significantly predict the risk of major vascular events (MVEs). Specifically, every doubling of sNfL concentrations increases the adjusted hazard ratio for cardiovascular death, nonfatal stroke, or myocardial infarction to 1.35. Consequently, this biomarker offers a unique perspective on the systemic health of AF patients.
Furthermore, the study highlighted that higher sNfL levels correlate with increased all-cause mortality and heart failure-related hospitalizations. Interestingly, these associations remained robust even after adjusting for traditional risk factors like age, renal function, and prior stroke history. Therefore, sNfL may serve as a powerful tool for clinicians to identify high-risk individuals who require closer monitoring.
Integrating sNfL into standard risk assessment could transform AF management. While current scores focus on clinical history, this blood-based biomarker captures active physiological injury. Additionally, its predictive value for non-neurological outcomes like heart failure suggests that sNfL reflects broader vascular and systemic stress. Clinicians can benefit from this objective measurement to refine patient prognosis and personalize care.
Monitoring sNfL levels can help clinicians identify AF patients at higher risk for cardiovascular death and heart failure, allowing for more intensive monitoring and earlier interventions.
No, latest research from the SWISS-AF cohort indicates it is also a strong independent predictor of major vascular events and all-cause mortality in patients with atrial fibrillation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Serum neurofilament light chain (sNfL) is identified as a robust biomarker for predicting major vascular events and mortality in atrial fibrillation patient...
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
